Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
468 |
|
Actual shortage: | 52 (11%) | |
Anticipated shortage: | 19 (4%) | |
Avoided shortage: | 9 (2%) | |
Resolved: | 388 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
52 (10%) |
|
Overdue reports |
12 (15%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144047 |
TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-22 | 2024-04-05 | 211102 |
TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-17 | 2024-02-29 | 216290 |
TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-20 | 2024-06-07 | 222839 |
DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-25 | 2024-04-19 | 223265 |
QUETIAPINE FUMARATE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-25 | 2024-04-14 | 223281 |
QUETIAPINE FUMARATE XR | 50MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223344 |
QUETIAPINE FUMARATE XR | 300MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223365 |
QUETIAPINE FUMARATE XR | 400MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223373 |
QUETIAPINE FUMARATE XR | 200MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223380 |
GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-05-28 | 223453 |
GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-26 | 2024-05-29 | 223456 |
ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-27 | 2024-05-17 | 223485 |
ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-06-06 | 2024-06-06 | 229797 |
OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-10-01 | 2018-10-31 | 62783 |
OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |